Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology

Psychedelic drug ayahuasca could help in battle against cancer, researcher says

by Eric W. Dolan
January 26, 2014
in Psychopharmacology
Share on TwitterShare on Facebook
Stay on top of the latest psychology findings: Subscribe now!

Peruvian woman preparing ayahuasca by Periodismo ItineranteA powerful psychedelic brew consumed by shamans deep in the Amazon could help in the fight against cancer and should be researched, according to a Brazilian scientist.

Ayahuasca — meaning the “vine of the souls” — is traditionally prepared using the Banisteriopsis caapi vine and Psychotria viridis leaves, though other combinations of plants are sometimes used. Psychotria viridis contains N,N-dimethyltryptamine (DMT) in the leaves, while Banisteriopsis caapi contains beta-carbolines such as harmine and harmaline.

For centuries, the psychedelic brew has been used in shamanistic healing rituals. A Natural Geographic reporter who participated in an ayahuasca ritual described the experience as “terrifying—but enlightening.”

Eduardo E. Schenberg of the Federal University of Sao Paulo thinks some of the healing powers attributed to ayahuasca deserve scientific attention, particularly when it comes to cancer.

“There is enough available evidence that ayahuasca’s active principles, especially DMT and harmine, have positive effects in some cell cultures used to study cancer, and in biochemical processes important in cancer treatment, both in vitro and in vivo,” he wrote in an article published in SAGE Open Medicine. “Therefore, the few available reports of people benefiting from ayahuasca in their cancer treatment experiences should be taken seriously, and the hypothesis presented here, fully testable by rigorous scientific experimentation, helps to understand the available cases and pave the way for new experiments.”

Rumors of ayahuasca helping people with cancer are common, according to Schenberg, and there are at least nine case reports of cancer patients using ayahuasca during their treatment. Of these nine reports, three showed improvements after consuming the psychedelic brew.

Rumors and less than a dozen case reports are hardly substantial evidence. But the physiological effects of the drug suggests there might be some truth behind them, Schenberg said.

DMT produces a powerful psychedelic experience by binding to serotonin receptors in the brain. More importantly, for Schenberg, the drug also binds to the sigma 1 receptor, which is found throughout the body and is involved in many cellular functions. The sigma 1 receptor appears to be implicated in the death signalling of cancer cells.

In addition, harmine has been shown to induce the death of some cancer cells and inhibit the proliferation of human carcinoma cells.

Other physiological factors suggest the combination of DMT and harmine could have medically-important antitumor effects, though more research is need.

“In summary, it is hypothesized that the combined actions of β-carbolines and DMT present in ayahuasca may diminish tumor blood supply, activate apoptotic pathways, diminish cell proliferation, and change the energetic metabolic imbalance of cancer cells, which is known as the Warburg effect,” Schenberg  wrote. “Therefore, ayahuasca may act on cancer hallmarks such as angiogenesis, apoptosis, and cell metabolism. ”

DMT is currently prohibited as a Schedule I drug by the U.S. Controlled Substances Act and the international Convention on Psychotropic Substances. The drug is relatively unknown compared to other illicit substances like cannabis, but researchers have found that DMT appears to be increasing in popularity.

“If ayahuasca is scientifically proven to have the healing potentials long recorded by anthropologists, explorers, and ethnobotanists, outlawing ayahuasca or its medical use and denying people adequate access to its curative effects could be perceived as an infringement on human rights, a serious issue that demands careful and thorough discussion,” Schenberg wrote.

— —

Photo credit: Periodismo Itinerante (Creative Commons-licensed)

TweetSendScanShareSendPinShareShareShareShareShare

RELATED

Taking medicinal cannabis oil for insomnia does not impair cognition on the following day
Cannabis

Cannabis oil might help with drug-resistant epilepsy, study suggests

July 2, 2025

Nineteen patients with drug-resistant epilepsy experienced seizure freedom after cannabis oil treatment, with a median seizure-free duration of 245 days. Five remained seizure-free for over a year, and most reported improved quality of life and reduced seizure frequency.

Read moreDetails
Psychedelic compound blurs boundary between self and others in the brain, study finds
Ayahuasca

Psychedelic compound blurs boundary between self and others in the brain, study finds

July 2, 2025

A recent study found that a DMT/harmine formulation blurs the brain’s distinction between self and other faces, disrupting self-referential processing while preserving recognition of familiar faces, suggesting a neural basis for psychedelic-induced ego dissolution.

Read moreDetails
Researchers identify neural mechanism behind memory prioritization
MDMA

New study reveals how MDMA rewires serotonin and oxytocin systems in the brain

June 30, 2025

Researchers found that MDMA reduces anxiety and enhances social behavior in zebrafish by altering key neurochemical systems. The drug suppressed serotonin signaling, boosted oxytocin receptor expression, and modulated brain signaling proteins involved in emotional regulation.

Read moreDetails
Stimulant medication improves working memory of children with ADHD, study finds
ADHD

New study exposes gap between ADHD drug use and safety research in children

June 30, 2025

A nationwide Finnish study shows that children with ADHD stay on medication for over three years on average. Yet, controlled safety data for these medications in children exists for only one year, highlighting a gap in long-term evidence.

Read moreDetails
Regular psychedelic users exhibit different brain responses to self-related thoughts, study finds
Neuroimaging

Regular psychedelic users exhibit different brain responses to self-related thoughts, study finds

June 28, 2025

A new study suggests that regular users of psychedelics may process self-related thoughts differently at both psychological and brain levels, revealing altered patterns of brain activity during self-reflection compared to non-users who intend to try psychedelics.

Read moreDetails
Can Acacia catechu and Scutellaria baicalensis extracts enhance brain function?
Dementia

Ashwagandha extract boosts memory and cognition in people with mild cognitive impairment, study finds

June 27, 2025

Researchers found that a standardized extract of ashwagandha improved memory, attention, and spatial reasoning in adults with mild cognitive impairment, outperforming a placebo in a two-month clinical trial with no reported side effects.

Read moreDetails
Psychedelic use linked to increased risk of unusual visual experiences
Ayahuasca

Study links moderate awe in psychedelic ayahuasca journeys to better well-being

June 21, 2025

A new study published in the Journal of Psychoactive Drugs suggests that while awe can be transformative during ayahuasca retreats, there’s a limit. Experiences marked by excessive vastness were linked to lower well-being, challenging assumptions about awe’s universal benefits.

Read moreDetails
Cannabis intoxication alters metabolism, but frequent users show fewer effects
Cannabis

Regular cannabis use linked to changes in brain activity regulating movement

June 20, 2025

Researchers have discovered that frequent cannabis users show reduced spontaneous brain activity in the motor cortex, and this neural suppression is tied to cannabis use severity and response speed, even though overall task performance remained comparable to non-users.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Ketogenic diet raises brain blood flow by 22% and BDNF by 47% in new study

Small folds in the brain may hold key insights into Alzheimer’s and aging-related cognitive decline

New research suggests interparental conflict can spill over into a mother’s parenting style

Creativity in autism may stem from co-occurring ADHD, not autism itself

Cannabis oil might help with drug-resistant epilepsy, study suggests

New brain stimulation method shows promise for treating mood, anxiety, and trauma disorders

Peppermint tea boosts memory and attention—but why?

Psychedelic compound blurs boundary between self and others in the brain, study finds

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy